Link Securities | Caixabank (CABK) is considering a takeover bid for Portuguese bank Novo Banco. There are other interested ...

The chief executive of Banco BPI, the Portuguese arm of Spain’s CaixaBank, has pushed back against concerns over Spanish influence in Portugal’s banking sector, saying foreign investment has been ...

Portugal said Spanish lenders shouldn’t further increase their presence in the country, the latest sign of a European government wanting to intervene in potential banking deals.

Portugal is concerned about over-dependence on Spain in its banking sector and views an acquisition of its fourth-largest ...

Housing is unaffordable. Migrants are a flashpoint issue. The far right is here to stay. And Portugal is deeply divided.

Eight years after Portugal agreed to sell the remnants of what was once the country’s largest lender to Lone Star Funds, plans by the US investor to sell Novo Banco are reviving deep-seated ...

Eight years after Portugal agreed to sell the remnants of what was once the country’s largest lender to Lone Star Funds, plans by the US investor to sell Novo Banco are reviving deep-seated fears in ...

Crowd-free destinations are getting harder to find. Millions of tourists head to Spain and Portugal each year, and what’s meant to be a relaxing holiday can sometimes feel like a battle through ...

CaixaBank SA is among suitors exploring a potential acquisition of Novo Banco SA, the Portuguese lender backed by Lone Star Funds that is pursuing an initial public offering, according to people ...

Português (Portugal) Polski Português (Brasil) ... CAIXY) is reportedly considering the acquisition of Portuguese bank Novo Banco SA, according to Bloomberg, citing sources familiar with the matter.

[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday (May 7) it would drop gender representation requirements for its US business following executive orders by President Donald Trump to stop ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But that’s reflective of the tough times the Danish maker of Ozempic and ...